This inventor holds 76 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Cancer Immunotherapy (CPC class A61K). Top assignee: Corixa Corporation. Active years: 1998-2012.
Inventors with similar research interests:
Location History:
- King, WA (US) (1998)
- Seattle, WA (US) (2003)
- Remond, WA (US) (2005)
- Issaquah, WA (US) (2002 - 2011)
- Redmond, WA (US) (1999 - 2012)
- Menlo Park, CA (US) (2010 - 2012)
Company Filing History:
Years Active: 1998-2012
Areas of Expertise:
Title: Innovator Spotlight: Davin C Dillon - Pioneering Cancer Therapies
Introduction:
Davin C Dillon, a renowned inventor based in Redmond, WA (US), is a prolific figure in the field of medical innovations. With an impressive portfolio of 76 patents, Dillon's groundbreaking work in cancer therapy and diagnosis has significantly impacted the healthcare industry.
Latest Patents:
Dillon's recent patents showcase his dedication to advancing the treatment of cancer. One notable invention includes "Compositions and methods for the therapy and diagnosis of breast cancer," which focuses on utilizing immunogenic portions and polynucleotides for the diagnosis, prevention, and treatment of breast cancer. Another significant patent involves fusion proteins with multiple antigens for diagnosing and preventing tuberculosis infections.
Career Highlights:
Currently employed at Corixa Corporation, Dillon continues to drive forward cutting-edge research and development in the medical sector. His expertise and innovative approach have led to the successful patenting of numerous life-saving technologies that have the potential to revolutionize cancer treatment methodologies.
Collaborations:
Dillon's collaborative spirit is evident in his work with esteemed colleagues such as Jiangchun Xu and Steven G Reed. Together, they have combined their knowledge and skills to address complex medical challenges and develop novel solutions that benefit patients worldwide.
Conclusion:
In conclusion, Davin C Dillon's visionary contributions to the field of cancer therapy and diagnosis exemplify the power of innovation in improving healthcare outcomes. His remarkable patent portfolio is a testament to his unwavering commitment to pushing the boundaries of medical science and making a meaningful difference in the lives of those affected by cancer.